>>The crappier a biotech company is, the more vociferously its investors complain about Feuerstein’s articles.<<
Partly this is because the crappier the biotech company, the more negatives Feuerstein tends to write about it, and partly it is a reflection of the type of people who invest in crappy biotech companies.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.